September 4, 2018 - B. Riley FBR Annual Healthcare Conference
The B. Riley FBR Annual Healthcare Investor Conference will be held at the New York Marriott East Side. Over 50 publicly traded companies and privately-held firms will attend to showcase their stories and offer thought leadership in their respective areas of expertise to over 400 investors and corporate clients.
InflaRx N.V. will be represented by Niels Riedemann, CEO
on the panel “There is no point in chasing after complement disease”, which is part of Track 1: “The Great Debates: Controversies in Biotech.”
